Stocks · Health care · Pharmaceutical Preparations

Kiniksa Pharmaceuticals International, plc

KNSA Clue Score67
Fiscal year ends December CIK 0001730430 Results filed 27 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Michael R Megna
7 Apr 2026
Chief Accounting Officer
Exercised, kept
3,932
$1.00
$3.93K
Kimberly J Popovits
30 Jul 2025
Director
Exercised, kept
18,760
$15.47
$290.22K
Kimberly J Popovits
30 Jul 2025
Director
Exercised, kept
45,748
$10.36
$473.95K
John F. Paolini
27 Feb 2020
SVP & Chief Medical Officer
Exercised, kept
12,000
$1.86
$22.32K
John F. Paolini
5 Dec 2019
SVP & Chief Medical Officer
Exercised, kept
8,000
$1.86
$14.88K
John F. Paolini
7 Oct 2019
SVP & Chief Medical Officer
Exercised, kept
10,000
$1.86
$18.60K

What was left out

Form 4 filings counted 358
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 205
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 8,216,831
Sales filed before the plan box existed 7
History held since 29 May 2018